Floatz logo

Sulthiame

Epilepsy in Children

University Hospital, AngersActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the Epilepsy in Children cohort.

Asset / SponsorPhaseRating
MELATONIN
National Taiwan University Hospital
Phase 2/3B
Retigabine
Xenon Pharmaceuticals Inc.
Phase 3CCC
Fycompa
Eisai Inc.
Phase 2NR
Mgcnd00Ep1
MGC Pharmaceuticals d.o.o
Phase 2NR

Same molecule, other indications

Sulthiame is also rated in:

self-limited epilepsy with centrotemporal spikesDormant
B
Indicative ·
60 / 100
View asset →
epilepsyDormant
CC
Indicative ·
42 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →